Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Promazine 25mg tablets
0402010S0AAAEAE
|
Promazine hydrochloride | Promazine hydrochloride | Central Nervous System | 7,285 |
|
Brancico XL 50mg tablets
0402010ABBLADAV
|
Brancico XL | Quetiapine | Central Nervous System | 7,225 |
|
Oxeltra 10mg modified-release tablets
0407020ADBLAFAF
|
Oxeltra | Oxycodone hydrochloride | Central Nervous System | 7,220 |
|
Oxeltra 5mg modified-release tablets
0407020ADBLAAAK
|
Oxeltra | Oxycodone hydrochloride | Central Nervous System | 7,195 |
|
Methylphenidate 30mg modified-release capsules
0404000M0AAAVAV
|
Methylphenidate hydrochloride | Methylphenidate hydrochloride | Central Nervous System | 7,139 |
|
Atomoxetine 25mg capsules
0404000S0AAADAD
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | 7,129 |
|
Oxcarbazepine 600mg tablets
0408010D0AAADAD
|
Oxcarbazepine | Oxcarbazepine | Central Nervous System | 7,092 |
|
Oxycodone 10mg capsules
0407020ADAAADAD
|
Oxycodone hydrochloride | Oxycodone hydrochloride | Central Nervous System | 7,062 |
|
Transtec 35micrograms/hour transdermal patches
0407020B0BDAAAE
|
Transtec | Buprenorphine | Central Nervous System | 7,040 |
|
Biquelle XL 200mg tablets
0402010ABBIACAW
|
Biquelle XL | Quetiapine | Central Nervous System | 7,034 |
|
Rotigotine 6mg/24hours transdermal patches
0409010Z0AAACAC
|
Rotigotine | Rotigotine | Central Nervous System | 7,030 |
|
Zaluron XL 200mg tablets
0402010ABBHACAW
|
Zaluron XL | Quetiapine | Central Nervous System | 7,005 |
|
Fentanyl 37.5microgram/hour transdermal patches
0407020A0AABWBW
|
Fentanyl | Fentanyl | Central Nervous System | 6,959 |
|
Madopar 100mg/25mg dispersible tablets
0409010K0BBALAL
|
Madopar | Co-beneldopa (Benserazide/levodopa) | Central Nervous System | 6,957 |
|
Reboxetine 4mg tablets
0403040U0AAAAAA
|
Reboxetine | Reboxetine | Central Nervous System | 6,913 |
|
Fluoxetine 20mg/5ml oral solution sugar free
0403030E0AAAHAH
|
Fluoxetine hydrochloride | Fluoxetine hydrochloride | Central Nervous System | 6,889 |
|
Oxypro 30mg modified-release tablets
0407020ADBSAEAR
|
Oxypro | Oxycodone hydrochloride | Central Nervous System | 6,870 |
|
Matrifen 75micrograms/hour transdermal patches
0407020A0BEADAG
|
Matrifen | Fentanyl | Central Nervous System | 6,801 |
|
Topiramate 50mg capsules
040801050AAAWAW
|
Topiramate | Topiramate | Central Nervous System | 6,783 |
|
Zaluron XL 400mg tablets
0402010ABBHAEAY
|
Zaluron XL | Quetiapine | Central Nervous System | 6,775 |
|
Disulfiram 200mg tablets
0410010B0AAAAAA
|
Disulfiram | Disulfiram | Central Nervous System | 6,761 |
|
Matrifen 100micrograms/hour transdermal patches
0407020A0BEAEAH
|
Matrifen | Fentanyl | Central Nervous System | 6,751 |
|
Fencino 50micrograms/hour transdermal patches
0407020A0BQACAF
|
Fencino | Fentanyl | Central Nervous System | 6,730 |
|
Paracetamol 120mg/5ml oral suspension paediatric
0407010H0AAAIAI
|
Paracetamol | Paracetamol | Central Nervous System | 6,729 |
|
Durogesic DTrans 25micrograms/hour transdermal patches
0407020A0BBAIAE
|
Durogesic | Fentanyl | Central Nervous System | 6,724 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.